Economic and outcomes aspects of venous thromboembolic disease. [Review]

MedStar author(s):
Citation: Critical Care Clinics. 28(1):113-23, vii, 2012 Jan.PMID: 22123103Institution: MedStar Washington Hospital CenterDepartment: Medicine/Pulmonary-Critical CareForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Intensive Care/ec [Economics] | *Venous Thromboembolism/ec [Economics] | Health Policy | Humans | Intensive Care Units/ec [Economics] | Intensive Care/mt [Methods] | Randomized Controlled Trials as Topic | Risk Factors | Treatment Outcome | United States/ep [Epidemiology] | Venous Thromboembolism/ep [Epidemiology] | Venous Thromboembolism/pc [Prevention & Control]Year: 2012Local holdings: Available online from MWHC library: 1996 - presentISSN:
  • 0749-0704
Name of journal: Critical care clinicsAbstract: Critically ill patients clearly face an increased risk for developing venous thromboembolic disease (VTE). Upon admission, all critical care patients should be immediately assessed for and prescribed VTE prophylaxis as it can significantly reduce VTE occurrence, its potential sequelae,and costs associated with VTE treatment. The financial burden associated with VTE is substantial. Longer ICU and hospital lengths of stay, pharmacy costs, and further outpatient management all contribute considerably to the economic burden of disease. The importance of this healthcare issue should motivate hospital administrators and physicians to systematically initiate thromboprophylaxis in all ICU patients.All authors: Chan CM, Shorr AFFiscal year: FY2012Digital Object Identifier: Date added to catalog: 2013-09-17
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 22123103 Available 22123103

Available online from MWHC library: 1996 - present

Critically ill patients clearly face an increased risk for developing venous thromboembolic disease (VTE). Upon admission, all critical care patients should be immediately assessed for and prescribed VTE prophylaxis as it can significantly reduce VTE occurrence, its potential sequelae,and costs associated with VTE treatment. The financial burden associated with VTE is substantial. Longer ICU and hospital lengths of stay, pharmacy costs, and further outpatient management all contribute considerably to the economic burden of disease. The importance of this healthcare issue should motivate hospital administrators and physicians to systematically initiate thromboprophylaxis in all ICU patients.

English

Powered by Koha